$ARNA Recent Headlines SP 500 back for another crack at

New Post Public Reply Private Reply Replies (0) Message Board

Mar 26, 2014 at 11:00 AM

$ARNA Recent Headlines

S&P 500 back for another crack at major support 12:21 p.m. Jan. 31, 2014 - Michael Ashbaugh
Arena shares surge as marketer doubles sales force for diet drug 12:41 p.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 1:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 2:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 2:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 7:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 10:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 10:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 7:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 7:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 8:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 1:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 12:07 p.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 8:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 8:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 1:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 2:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 4:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 3:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 10:32 a.m. July 30, 2012 - Val Brickates Kennedy

Direct To Consumer Television Advertising Marks The Tipping Point For Belviq Sales 9:34 a.m. March 24, 2014 - Seeking Alpha
March Madness: Final Four Investing Bracket 2014 6:36 p.m. March 20, 2014 - Seeking Alpha
Arena Down With Overall Market - Sales Data No Help 8:27 a.m. March 17, 2014 - Seeking Alpha
Interesting ARNA Put And Call Options For May 2nd 11:11 a.m. March 13, 2014 - TheStreet.com
Arena Sees Growth Continue With Belviq 4:01 p.m. March 7, 2014 - Seeking Alpha
Have Anti-Obesity Drug Companies Failed? 3:09 p.m. March 7, 2014 - Seeking Alpha
ARNA April 25th Options Begin Trading 11:09 a.m. March 6, 2014 - TheStreet.com
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data - Analyst Blog 10:58 a.m. March 5, 2014 - Zacks.com
Is A Short Squeeze Ahead for Arena Pharmaceuticals (ARNA)? - Tale of the Tape 9:23 a.m. March 4, 2014 - Zacks.com
10-K: ARENA PHARMACEUTICALS INC 4:52 p.m. March 3, 2014 - Edgar Online - (EDG = 10Q, 10K)
Company news for March 03, 2014 - Corporate Summary 10:06 a.m. March 3, 2014 - Zacks.com
Future Sales Of Arena Pharmaceuticals' BELVIQ: Let's Make Some Informed, Quantitative Predictions Using Expected Value 8:01 a.m. March 3, 2014 - Seeking Alpha
Yellen Comments Help Lift Dow 1.4% on Week 2:03 a.m. March 1, 2014 - Barrons.com
Arena Prescription Sales Up: Stops Stock Slide 5:28 p.m. Feb. 28, 2014 - Seeking Alpha
Arena Posts Wider Loss, Misses Ests - Analyst Blog 12:20 p.m. Feb. 28, 2014 - Zacks.com
Benzinga's Top #PreMarket Losers 7:15 a.m. Feb. 28, 2014 - benzinga.com
Arena's Belviq Sales To Hit $150 Million In 2014? 12:10 a.m. Feb. 28, 2014 - Seeking Alpha
Arena Falls On Quarterly Results 7:42 p.m. Feb. 27, 2014 - Seeking Alpha
Arena Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript 7:25 p.m. Feb. 27, 2014 - Seeking Alpha
Arena -5.2% AH on Q4 miss, guidance 5:19 p.m. Feb. 27, 2014 - Seeking Alpha

Momentum Indicators for Health Care Equities -- Research on Arena Pharma, Hemispherx Biopharma, PDL BioPharma and Celgene 8:16 a.m. March 20, 2014 - PR Newswire - PRF
Financial Results Releases and Schedules, Clinical Study Results, Partnerships, and Senior-Level Appointments - Analyst Notes on Arena, Horizon Pharma, Enanta, Vanda, and PTC 4:30 p.m. March 5, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2013 Financial Results 5:22 p.m. Feb. 27, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Provide Corporate Update and Report Financial Results on Thursday, February 27 9:00 a.m. Feb. 20, 2014 - PR Newswire - PRF
Brazilian Pharmaceutical Market 2014-2024 11:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Announces Filing for Marketing Authorization of BELVIQ® (lorcaserin HCl) in Brazil 9:00 a.m. Feb. 12, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences 9:00 a.m. Feb. 5, 2014 - PR Newswire - PRF
Healthcare Companies Announce Drug Launches, Upcoming Conference Calls, and Financial Results Schedules - Research Report on Bristol-Myers Squibb, Teva, Jazz, AmerisourceBergen and Arena 9:00 a.m. Jan. 9, 2014 - PR Newswire
Arena Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference 9:00 a.m. Jan. 6, 2014 - PR Newswire
Collaborations, FDA Approvals, Appointments, Patents, and Stock Movements - Research Report on Aetna, United Therapeutics, Perrigo, Arena Pharmaceuticals, and Keryx Biopharmaceuticals 9:00 a.m. Dec. 31, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 11:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Insiders Trend Analysis: Tiger Oil and Energy Inc, Groupon Inc, General Motors Company Arena Pharmaceuticals 11:47 a.m. Dec. 19, 2013 - ACCESSWIRE
Opening Buzzers: General Motors Company, Sunedison Inc, Nokia Corporation, Arena Pharmaceuticals 11:11 a.m. Dec. 17, 2013 - ACCESSWIRE
Stock Price Updates, FDA 510(k) Clearances, Conference Presentation and Resignations - Research Report on Gilead, Oculus Innovative Sciences, ARCA biopharma, Arena Pharma, and Tonix Pharma 9:00 a.m. Dec. 9, 2013 - PR Newswire
Bearish Stocks Analysis: Morgan Stanley, Microsoft Corporation, Arena Pharmaceuticals, Vale SA, JPMorgan Chase & Co 10:17 a.m. Dec. 6, 2013 - PR Newswire
Blue Chip Stock News: Ariad Pharmaceuticals, Citigroup Inc, Arena Pharmaceuticals, Market Vectors Gold Miners 10:45 a.m. Dec. 5, 2013 - ACCESSWIRE
Notable News Of The Day: BlackBerry Ltd, Arena Pharmaceuticals, Groupon Inc, Zynga Inc 10:56 a.m. Dec. 2, 2013 - ACCESSWIRE
Promising Partnerships, Stock Price Updates and Participation in Upcoming Healthcare Conferences - Research Report on Quest Diagnostics, Cigna, Arena, Theravance, and Volcano 9:00 a.m. Nov. 29, 2013 - PR Newswire
Arena Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference 9:00 a.m. Nov. 27, 2013 - PR Newswire
Trend Analysis Scan: Synovus Financial, Arena Pharmaceuticals, Facebook Inc, J.C. Penney Company, Citigroup 9:49 a.m. Nov. 26, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Damp or Dry: The Battle for Healthy Air in Colorado

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

D-Wave Faces Legal Questions After CFO Exit and Losses

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Pizza: The Unlikely Symbol of Universal Togetherness

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Ajman Spotlights Tourism at Arabian Travel Market 2026

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Larry Ellison's Moves Signal Confidence in Oracle's Future

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

U.S. Green Beret's Mission: Clearing Landmines in Ukraine

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...